Bragar Eagel & Squire, P.C. Is Investigating Hollysys, Cronos Group, and Talkspace and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Hollysys Automation Technologies Ltd. (NASDAQ: HOLI), Cronos Group, Inc. (NASDAQ: CRON), and Talkspace, Inc. (NASDAQ: TALK). Our investigations concern whether these companies have violated the federal securities laws andor engaged in other unlawful business practices. Additional information about each case can be found at the link provided.

Hollysys Automation Technologies Ltd. (NASDAQ: HOLI)

On November 2, 2021, Hollysys filed a notice with the U.S. Securities and Exchange Commission stating that the Company could not timely file its annual report for the period ended June 30, 2021 because of a "delay in collecting supporting documents and information." Hollysys also disclosed that it had replaced Ernst & Young Hua Ming LLP as its independent auditor.

On this news, Hollysys's stock price fell $5.69 per share, or 29%, to close at $13.70 per share on November 3, 2021.

For more information on the Hollysys investigation go to: https://bespc.com/cases/HOLI

Cronos Group, Inc. (NASDAQ: CRON)

On November 9, 2021, Cronos filed a Form 8-K with the U.S. Securities and Exchange Commission, stating that "[o]n November 8, 2021, Cronos Group Inc. . . . determined that it will be required to restate its previously issued unaudited interim financial statements for the three and six months ended June 30, 2021 previously filed on Form 10-Q on August 6, 2021" and advising that "[t]he Company's financial statements for this period should therefore no longer be relied upon." Cronos further stated that "[t]he Company concluded that it should have recorded an impairment charge of not less than $220 million on goodwill and indefinite-lived intangible assets in its U.S. reporting unit for the three and six months ended June 30, 2021. The Company will restate its unaudited interim financial statements for the three and six months ended June 30, 2021, accordingly." According to Cronos, the Company "is also evaluating whether to record an additional impairment in the three and nine months ended September 30, 2021."

On this news, Cronos's stock price fell $1.01 per share, or 15.05%, to close at $5.70 per share on November 9, 2021.

For more information on the Cronos Group investigation go to: https://bespc.com/cases/CRON

Talkspace, Inc. (NASDAQ: TALK)

On November 15, 2021, post-market, Talkspace issued a press release "announc[ing] . . . that its co-founder and CEO, Oren Frank, has decided to step down from his position as CEO and Board member of Talkspace, effective today." Shortly thereafter on the same day, Talkspace issued a press release reporting its financial results for the third quarter of 2021. Among other items, Talkspace disclosed that its net revenue for the quarter "came in below management expectations due to a lower number of B2C [business-to-consumer] customers and a one-time non-cash reserve adjustment for credit losses on receivables related to prior periods."

On this news, the Company's share price declined by $1.23 per share, or approximately 36.3%, from $3.39 per share to close at $2.16 per share on November 16, 2021.

For more information on the Talkspace investigation go to: https://bespc.com/cases/TALK

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com . Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Alexandra B. Raymond, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

CRON:CA,CRON
The Conversation (0)
Cannabis Investing

Ongoing Growth in North America’s Cannabis Space

An article curated by Bazinga highlighted the cannabis market trends from last week. Even though last week was short, the cannabis sector was a busy. The article went on to highlight a number of the cannabis companies looking preparing for their IPOs, among other cannabis related news.

The article went on to highlight the Flowr Corporation as one of numerous companies looking to go public by the end of the year. Flowr’s management team is responsible for the creation and success of MedReleaf, an R&D focused company in the medical cannabis space. In preparation for its RTO in Canada, the company has raised $36 million in financing.

Keep reading...Show less

Trulieve Announces Purchase of 8% Senior Secured Notes due 2026

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the open market purchase of 57,000 of its USD $1,000 face value senior secured notes due October 6, 2026 (the "Notes") for a purchase price of USD $47.6 million which represents a 16.5% discount to par, plus accrued interest. The Notes trade on the Canadian Securities Exchange under the symbol "TRUL.NT.U".

Trulieve logo (PRNewsfoto/Trulieve Cannabis Corp.)

This press release is for information purposes only and is not an offer to purchase, a solicitation of an offer to sell the Notes or any other securities of the Company.

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona , Florida , and Pennsylvania . Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve
Instagram: @Trulieve_
Twitter: @Trulieve

Investor Contact
Christine Hersey , Vice President of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Phil Buck , Corporate Communications Manager
+1 (406) 370-6226
Philip.Buck@Trulieve.com

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/trulieve-announces-purchase-of-8-senior-secured-notes-due-2026-301935538.html

SOURCE Trulieve Cannabis Corp.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/September2023/21/c4002.html

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Cronos launches leading medical brand PEACE NATURALS® in Germany

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") announced today that it shipped its first order of bulk cannabis, which will be sold under the PEACE NATURALS® brand in Germany. In July, Cronos signed a distribution agreement with Cansativa Group ("Cansativa"), one of the leading distributors of medical cannabis in Germany. Cansativa is a market leader in the medical cannabis market and is a driving force in the German cannabis industry. Cansativa has a network of approximately 2,000 pharmacies domestically; they currently supply around 300,000 patients in Germany's medical market.

"Re-entering the German market, which has about 83 million people, is a significant milestone for Cronos and we look forward to expanding our reach and brand awareness in Germany with the help of Cansativa," said Mike Gorenstein, Chairman, President, and CEO, Cronos. "We intend to establish our PEACE NATURALS ® brand as a top medical brand, similar to the brand's reputation in Israel. We will continue to push forward on new market growth opportunities and expand our portfolio of borderless products."

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Trulieve Opening Medical Cannabis Dispensary in Pace, Florida

Company celebrates grand opening and expands medical cannabis access to patients in Escambia and Santa Rosa counties

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States today announced the opening of a new medical dispensary located at 5037 Hwy 90, Pace, Fla. The new location will be open 9 a.m. 8:30 p.m. Monday through Saturday and 11 a.m. 8 p.m. on Sundays .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Trulieve Employee Training Program Earns Multiple Gold Awards for Excellence

Leading cannabis multi-state operator recognized for innovative, best in class human capital management ("HCM") strategy via implementation of its TruU-GROW Employee Training Program

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States today announced its TruU-GROW cultivation training program has received six Gold awards for excellence in the 2023 Brandon Hall Group HCM Excellence Awards™. The awards recognize best practices for initiatives in Learning and Development, Talent Management, Leadership Development, Talent Acquisition, Human Resources, Sales Performance, Diversity, Equity & Inclusion, and the Future of Work. Prior gold medal award winners include leading multinational companies such as Merck & Co., Kraft Heinz, IBM, Chevron, and Deloitte.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Trulieve Announces September 2023 Event Participation

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced planned event participation in September.

Trulieve logo (PRNewsfoto/Trulieve Cannabis Corp.)

  • ATB Capital Markets 2023 Life Sciences Institutional Investor Conference, September 20, 2023 : Founder and CEO Kim Rivers will participate in a fireside chat and investor meetings.

  • Benzinga Cannabis Capital Conference, September 27 - 28, 2023 : Founder and CEO Kim Rivers will give a keynote speech on September 27 , Director of Digital Marketing Iram Cesani will participate in a panel discussion on September 27 , and Board Member Susan Thronson will participate in a panel discussion on September 28 .

Information about our events, links to events where available, and slide presentations can be found at: https://investors.trulieve.com/events

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona , Florida , and Pennsylvania . Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve
Instagram: @Trulieve_
Twitter: @Trulieve

Investor Contact
Christine Hersey , Vice President of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Phil Buck , Corporate Communications Manager
+1 (406) 370-6226
Philip.Buck@Trulieve.com

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/trulieve-announces-september-2023-event-participation-301920006.html

SOURCE Trulieve Cannabis Corp.

Cision View original content to download multimedia: https://www.newswire.ca/en/releases/archive/September2023/07/c0903.html

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Australia Cannabis Investing: What You Need to Know

Australia Cannabis Investing: What You Need to Know

Since the legalisation of medical cannabis in 2016, Australia has been steadily developing its marijuana industry — and it’s been attracting attention from international players and investors.

With a quickly growing population of over 27 million people and a robust agricultural industry, the country could be positioned to mould itself into a major force in the international cannabis space.

Here, the Investing News Network takes a look at how the cannabis industry in Australia has been shaping up since legalisation, and what these developments could mean for investors. Read on to see what you need to know about investing in cannabis down under.

Keep reading...Show less

Latest Press Releases

Related News

×